Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
Presidential Award - High Impact Publication Honoree
David M. Brown
(Recipient)
Weill Cornell Medical College
Academic Institute
Houston Methodist
Department of Ophthalmology-Blanton Eye Institute
Houston Methodist Hospital
Prize
:
Prize (including medals and awards)
Description
MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Awarded date
2025
Fingerprint
Neovascular Age-related Macular Degeneration (nAMD)
100%
Subretinal Fluid
100%
Merlin
100%
Brolucizumab
100%
Age-Related Macular Degeneration
100%
X